Colour Coded Duplex Ultrasound of Native Arterio-venous Fistula for Haemodialysis With Venous Pressure Measurement Using Controlled Compression Ultrasound as a Predictor for Shunt Maturation in the Early Postoperative Phase
The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2010 by University of Zurich.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
University of Zurich
Information provided by:
University of Zurich
ClinicalTrials.gov Identifier:
NCT01001000
First received: October 22, 2009
Last updated: June 28, 2010
Last verified: June 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Prospective observational ultrasound study of native arterio-venous fistula for haemodialysis with venous pressure measurement using controlled compression ultrasound.
| Condition | Intervention |
|---|---|
|
Renal Insufficiency |
Procedure: Ultrasound (Pressure measurement) |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
Resource links provided by NLM:
Genetics Home Reference related topics:
capillary malformation-arteriovenous malformation syndrome
Parkes Weber syndrome
U.S. FDA Resources
Further study details as provided by University of Zurich:
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Patients after creation of a native arterio-venous fistula at the cephalic vein for hemodialysis access
Criteria
Inclusion criteria:
- Patients after creation of a native arterio-venous fistula at the cephalic vein for hemodialysis access;
- Informed consent.
Exclusion criteria:
- Former creation of a native arterio-venous fistula at the same arm;
- Known upper extremity occlusive arterial disease;
- Situation when ultrasound examination is not suitable: extreme swelling of the arm, post-operative pain, hematoma, local infections.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01001000
Contacts
| Contact: 01 Studienregister MasterAdmins | +41 (0)44 255 11 11 |
Locations
| Switzerland | |
| Recruiting | |
| Zurich, Switzerland | |
Sponsors and Collaborators
University of Zurich
Investigators
| Study Director: | 01 Studienregister MasterAdmins | UniversitaetsSpital Zuerich |
More Information
No publications provided
| Responsible Party: | Christoph Thalhammer, MD, USZ |
| ClinicalTrials.gov Identifier: | NCT01001000 History of Changes |
| Other Study ID Numbers: | CT-01-2009-USZ |
| Study First Received: | October 22, 2009 |
| Last Updated: | June 28, 2010 |
| Health Authority: | Switzerland: Ethikkommission |
Additional relevant MeSH terms:
|
Arteriovenous Fistula Renal Insufficiency Arteriovenous Malformations Vascular Malformations Cardiovascular Abnormalities Cardiovascular Diseases Vascular Fistula |
Vascular Diseases Congenital Abnormalities Fistula Pathological Conditions, Anatomical Kidney Diseases Urologic Diseases |
ClinicalTrials.gov processed this record on May 23, 2013